Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumonia
NCT04418128
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
84
Enrollment
OTHER
Sponsor class
Conditions
Corona Virus Infection
COVID-19
Interventions
DRUG:
Nafamostat Mesylate
Sponsor
Gyeongsang National University Hospital